Table 1 Overview of the prevalence–incidence data set used for model calibration.

From: Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malaria

Study

Site, Country

Year (s)

PfPR2–10

Treat.

τACD*

Threshold

Ba et al.54†

Ndiop, Senegal

1993

0.26

0.639

1

>3,600 p μl−1

Bloland et al.55†

Asembo Bay, Kenya

1992

0.79

0.870

14

Age specific

Bonnet et al.37

Koundou, Cameroon

1997–1998

0.72

0.807

1

>1,000 p μl−1

 

Ebolakouno, Cameroon

1997–1998

0.66

0.807

1

>1,000 p μl−1

Bougouma et al.56,57†

Saponé, Burkina Faso

2007

0.67

0.770

3

>2,500 p μl−1

Coulibaly et al.58†

Bandiagara, Mali

1999

0.29

0.944

7

Any patent

Diallo et al.59,60

Dakar, Senegal

1996–1997

0.014

0.495

7

Any patent

 

S. Dakar,

1994

0.003

0.495

7

Any patent

Dicko et al.61

Donéguébougou, Mali

1999–2000

0.403

0.944

7

Any patent

 

Sotuba, Mali

1999–2000

0.086

0.944

7

Any patent

Fillol et al.62†

Niakhar, Senegal

2003

0.22

0.820

7

>3,000 p μl−1

Greenwood et al.63†

Farafenni, The Gambia

1981–1982

0.32

0.682

30

Age specific

Guinovart et al.22

Manhiça, Mozambique

2003–2005

0.20

0.820

·

Any patent

Henry et al.64

Katiola, Côte d’Ivoire

1997–1998

0.91

0.686

1

Age specific

 

Korhogo, Côte d’Ivoire

1997–1998

0.88

0.686

1

Age specific

 

Korhogo, Côte d’Ivoire

1997–1998

0.83

0.686

1

Age specific

Loha et al.65†

Chano Mille, Ethiopia

2009–2011

0.044

0.812

7

Any patent

Lusingu et al.66

Mgome, Tanzania

2001

0.91

0.850

30

Age specific

 

Ubiri, Tanzania

2001

0.27

0.850

30

Age specific

 

Magamba, Tanzania

2001

0.067

0.850

30

Age specific

Molez et al.67†

Barkedji, Senegal

1994–1995

0.098

0.443

10

Age specific

Mwangi et al.68,69

Ngerenya, Kenya

1999–2001

0.25

0.870

7

>2,500 p μl−1

 

Chonyi, Kenya

1999–2001

0.41

0.870

7

>2,500 p μl−1

Nebie et al.70†

Balonghin, Burkina Faso

2003

0.63

0.722

1

>5,000 p μl−1

Owusu-Agyei et al.71

Kintampo, Ghana

2004

0.72

0.922

2.33

>5,000 p μl−1

Rogier et al.72

Dielmo, Senegal

1990

0.89

0.639

1

Sharp increase

Saute et al.73

Manhiça, Mozambique

1996–1999

0.26

0.384

7

Any patient

Schellenberg et al.47

Ifakara, Tanzania

2000–2001

0.19

0.850

7

Any patient

Thompson et al.74

Matola, Mozambique

1992–1995

0.38

0.526

1

Age specific

Trape et al.75†

Linzolo, Republic of Congo

1983–1984

0.79

0.788

1

p/leu. >2

Trape et al.40

Dielmo, Senegal

2007–2008

0.20

0.950

2.33

p/leu. >3.5

Velema et al.76†

Pahou, Benin

1989

0.51

0.661

30

>1,000 p μl−1

  1. ACD, active case detection; PfPR, P. falciparum parasite rate.
  2. *Here τACD denotes the period of ACD in days for each study. Note also that in the Threshold column p μl−1 stands for parasites per microlitre, and p/leu. the ratio of parasites to leucocytes.
  3. †Highlights studies not included in the previous Griffin et al.8 model calibration.
  4. ·Symbol denotes the one study here that did not conduct ACD, but was included here for consistency with the previous analysis of Griffin et al.
Back to article page